These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32302695)

  • 1. Targeted delivery of miRNA based therapeuticals in the clinical management of Glioblastoma Multiforme.
    Pottoo FH; Javed MN; Rahman JU; Abu-Izneid T; Khan FA
    Semin Cancer Biol; 2021 Feb; 69():391-398. PubMed ID: 32302695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.
    Costa PM; Cardoso AL; Custódia C; Cunha P; Pereira de Almeida L; Pedroso de Lima MC
    J Control Release; 2015 Jun; 207():31-9. PubMed ID: 25861727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioreducible Polymeric Nanoparticles Containing Multiplexed Cancer Stem Cell Regulating miRNAs Inhibit Glioblastoma Growth and Prolong Survival.
    Lopez-Bertoni H; Kozielski KL; Rui Y; Lal B; Vaughan H; Wilson DR; Mihelson N; Eberhart CG; Laterra J; Green JJ
    Nano Lett; 2018 Jul; 18(7):4086-4094. PubMed ID: 29927251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics.
    Shea A; Harish V; Afzal Z; Chijioke J; Kedir H; Dusmatova S; Roy A; Ramalinga M; Harris B; Blancato J; Verma M; Kumar D
    Cancer Med; 2016 Aug; 5(8):1917-46. PubMed ID: 27282910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing nanomedicine for therapeutic intervention in glioblastoma.
    Gutkin A; Cohen ZR; Peer D
    Expert Opin Drug Deliv; 2016 Nov; 13(11):1573-1582. PubMed ID: 27292970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review.
    Ahir BK; Ozer H; Engelhard HH; Lakka SS
    Crit Rev Oncol Hematol; 2017 Dec; 120():22-33. PubMed ID: 29198335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Targets and Nanoparticulate Systems Designed for the Improved Therapeutic Intervention in Glioblastoma Multiforme.
    Akhter MH; Rizwanullah M; Ahmad J; Amin S; Ahmad MZ; Minhaj MA; Mujtaba MA; Ali J
    Drug Res (Stuttg); 2021 Mar; 71(3):122-137. PubMed ID: 33167048
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Gallego L; Ceña V
    Expert Opin Drug Deliv; 2020 Nov; 17(11):1541-1554. PubMed ID: 32791861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy.
    Nikaki A; Piperi C; Papavassiliou AG
    Expert Opin Investig Drugs; 2012 Oct; 21(10):1475-88. PubMed ID: 22809292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances on Glioblastoma Multiforme and Nano-drug Carriers: A Review.
    Liao W; Fan S; Zheng Y; Liao S; Xiong Y; Li Y; Liu J
    Curr Med Chem; 2019; 26(31):5862-5874. PubMed ID: 29768997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functionalized nanogels carrying an anticancer microRNA for glioblastoma therapy.
    Shatsberg Z; Zhang X; Ofek P; Malhotra S; Krivitsky A; Scomparin A; Tiram G; Calderón M; Haag R; Satchi-Fainaro R
    J Control Release; 2016 Oct; 239():159-68. PubMed ID: 27569663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.
    Kim SS; Harford JB; Pirollo KF; Chang EH
    Biochem Biophys Res Commun; 2015 Dec; 468(3):485-9. PubMed ID: 26116770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment.
    Ganipineni LP; Danhier F; Préat V
    J Control Release; 2018 Jul; 281():42-57. PubMed ID: 29753958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicine associated with photodynamic therapy for glioblastoma treatment.
    de Paula LB; Primo FL; Tedesco AC
    Biophys Rev; 2017 Oct; 9(5):761-773. PubMed ID: 28823025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
    Wang D; Wang C; Wang L; Chen Y
    Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput screening uncovers miRNAs enhancing glioblastoma cell susceptibility to tyrosine kinase inhibitors.
    Cunha PP; Costa PM; Morais CM; Lopes IR; Cardoso AM; Cardoso AL; Mano M; Jurado AS; Pedroso de Lima MC
    Hum Mol Genet; 2017 Nov; 26(22):4375-4387. PubMed ID: 28973155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
    Tabibkhooei A; Izadpanahi M; Arab A; Zare-Mirzaei A; Minaeian S; Rostami A; Mohsenian A
    Clin Neurol Neurosurg; 2020 Mar; 190():105652. PubMed ID: 31896490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between magnetic resonance imaging features and miRNA gene expression in patients with glioblastoma multiforme.
    Li WB; Chen HY; Zhang W; Yan W; Shi R; Li SW; Jiang T
    Chin Med J (Engl); 2013; 126(15):2881-5. PubMed ID: 23924460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-targeted nanotherapeutics: overcoming treatment barriers for glioblastoma.
    Wadajkar AS; Dancy JG; Hersh DS; Anastasiadis P; Tran NL; Woodworth GF; Winkles JA; Kim AJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jul; 9(4):. PubMed ID: 27813323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.